Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, today announced Allergan Medical Institute (AMI) will open three new ...

Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...

CollPlant Biotechnologies , or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue ...

REHOVOT, Israel - CollPlant Biotechnologies (NASDAQ: CLGN), currently valued at $40.7 million in market capitalization, ...

Non-Surgical Fat Reduction MarketThe non-surgical fat reduction market is projected to grow at a CAGR of 5.6%, expanding from USD 1,700.5 million in 2024 to USD 2,932.3 million by 2034. This growth is ...

Asia Pacific medical device market will grow by 8.4% annually with a total addressable market cap of $2.06 trillion over 2023-2032, driven by the prevalence of infectious diseases as well as the ...

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

Pigmented Lesion Treatment MarketThe pigmented lesion treatment market is set to expand from USD 3,591.3 million in 2023 to USD 7,614.7 million by 2033, growing at a CAGR of 7.8% over the forecast ...